India's Deep Tech Revolution: 3,600 Startups, $2.6 Billion Raised, and a KPMG Report That Should Terrify India's Competitors

The KPMG report on India's startup ecosystem, circulated in the first two weeks of June 2026, contains a data point that deserves to be elevated from footnote to headline: deep tech — startups in AI, robotics, biotech, quantum computing, and related technical fields — now accounts for approximately 12% of India's startup base, with more than 3,600 companies. More significantly, deep tech funding held up better than the broader market despite the year-on-year H1 decline. The Indian startup ecosystem is not just recovering from the 2022–23 funding winter. It is restructuring around genuinely harder, more defensible, more scientifically intensive businesses.

The $2.6 billion in total funding raised by Indian AI startups to date (Inc42's Indian AI Startup Tracker, 170+ companies) understates the actual investment flowing into the broader deep tech category. When biotech, advanced manufacturing, climate technology, and defence technology companies are included, the total deep tech funding figure is substantially larger. More importantly, the quality of these investments — measured by technical differentiation, seniority of investors, and strategic nature of the problems addressed — is higher than at any previous point in India's startup history.

The AI dimension is the largest and most visible. India's AI market is on course to become a $126 billion opportunity by 2030. More than 170 AI startups have raised over $2.6 billion collectively, building AI models, devices, and enterprise tools across applications from multilingual voice interfaces to industrial automation. On June 10, 2026, a unified AI platform announcement by major tech giants reshaped the competitive landscape — but India's domain-specific AI companies, with differentiation rooted in market specificity, are positioned to withstand this pressure.

Robotics is the deep tech sector with the most immediate commercial urgency. The China Plus One supply chain diversification trend — multinational manufacturers reducing dependence on China by moving production to India — has created acute need for manufacturing automation. Integra Robotics (pre-Series A raise, $1.12 million, June 2026) is building robotic arms, UGVs, vision systems, and subsea automation platforms. Nine years of patient building before institutional capital arrived — the hallmark of deep tech done right.

Biotech represents deep tech at its most patient and most impactful. Immuneel Therapeutics' Rs 100+ crore Series B for CAR-T cell therapy development represents a new chapter: Indian biotech companies raising institutional capital to develop genuinely novel medicines at Indian cost points — making therapies that cost hundreds of thousands of dollars in the West accessible to patients globally. India's pharmaceutical sector has supplied 40% of US generic drug consumption. Now it is moving upstream into drug discovery.

Quantum computing is the category at the earliest stage but with potentially the largest long-term implications. India's National Quantum Mission has made significant government investments in quantum research, and several university-affiliated startups are beginning to commercialise early-stage quantum algorithms and quantum-safe cryptography. The KPMG insight that resonates most deeply: a country's ability to turn science and engineering into defendable business assets is the truest measure of innovation ecosystem maturity. By this measure, India's deep tech sector in 2026 is doing something that should concern its competitors: it is proving it can build, fund, and scale genuinely hard technology.